Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.
Ashita DebnathKelly E PillingerAlysa J MartinDavid DobrzynskiAndrew CameronStephanie ShulderPublished in: The Annals of pharmacotherapy (2022)
Our study found no difference in clinical outcomes between nCP-CRE and CSE infections. Application of this study with future studies would help in determining optimal regimens for these infections.